The goal of this clinical trial is to investigate the effectiveness of yoga for patients with chronic low back pain and high risk of poor prognosis. The main question it aims to answer is: \- In patients with back pain and high risk of poor prognosis, what is the effectiveness of yoga plus education on reducing pain and disability compared to a control group receiving education alone? A total of 110 patients with chronic low back pain and classified as high risk of poor prognosis according to the Orebro Musculoskeletal Pain Screening Questionnaire (i.e. score ≥ 50 points out of 100) will be recruited for this study. Participants will be randomized into two groups: yoga and control. The yoga group will receive a 3-month course of yoga program consisting of two sessions per week and 3 educational classes. The control group will receive 3 educational classes over a 12-week period. Outcome measures will be assessed at baseline, at post-intervention (i.e. 3-months post randomization) and at 6-month follow up (i.e. 6-months post randomization).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
110
Each educational class will last for 1 hour and consists of evidence-based information about low back pain, including, for example, self-management strategies, pain education, reassurance and common misconceptions about back pain.
Participants in the intervention group will receive, in addition to the educational classes, a course of yoga program led by certified yoga instructors. The program consists of a 60-min group session with up to 10 participants, delivered twice a week for 12 weeks.
IPSEMG - Instituto de Previdência dos Servidores do Estado de Minas Gerais
Belo Horizonte, Minas Gerais, Brazil
Disability
Roland Morris Disability Questionnaire (RMDQ) (0-24 scale)
Time frame: Post-intervention (i.e. 3 months after randomisation)
Disability
Roland Morris Disability Questionnaire (RMDQ) (0-24 scale)
Time frame: 6 months after randomisation
Pain intensity
Numerical Rating Scale for Pain assessment (NRS) (0-10 scale)
Time frame: Post-intervention (i.e. 3 months after randomisation) and at 6-month follow-up
Quality of life
EuroQol Visual Analogue Scale (EQ-VAS) (0-100 scale)
Time frame: Post-intervention (i.e. 3 months after randomisation) and at 6-month follow-up
Depressive symptoms
Center for Epidemiological Studies - Depression (CES-D) (0-60 scale)
Time frame: Post-intervention (i.e. 3 months after randomisation) and at 6-month follow-up
Pain self-efficacy
Pain Self-Efficacy Questionnaire (PSEQ) (0-60)
Time frame: Post-intervention (i.e. 3 months after randomisation) and at 6-month follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.